Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Alterations in Circulating Lymphoid Populations after Post-Transplant Cyclophosphamide Administration in Haploidentical Hemopoietic Cell Transplantation

Kifah Shahin, PhD, Zamil Mattar, Kenneth Bradstock, MBBS, PhD

Blood (2016) 128 (22): 5798.

https://doi.org/10.1182/blood.V128.22.5798.5798

Published: 2016

Journal Articles

Expanded Phenotypic and Genetic Heterogeneity in the Clinical Spectrum of FPD-AML: Lymphoid Malignancies and Skin Disorders Are Common Features in Carriers of Germline RUNX1 Mutations

Anna L Brown, PhD, Christopher N Hahn, PhD, Catherine Carmichael, Ella Wilkins, Milena Babic, BMPharBio (Hons), Chan-Eng Chong, PhD, Xiao-Chun Li, Joelle Michaud, Ping Cannon, Nicola Poplawski, MBChB, DipPaed, FRACP, MD, Meryl Altree, Kerry Phillips, Louise Jaensch, Miriam Fine, Andreas W Schreiber, PhD, Jinghua Feng, PhD, Lesley Rawlings, PhD, Cassandra Vakulin, Carolyn Butcher, Richard D'Andrea, PhD, Ian D Lewis, MBBS, PhD FRACP, FRCPA, Nigel Patton, Cecily Forsyth, MBBS, FRACP, FRCPA, Sally Mapp, PhD MD, Helen Mar Fan, Rachel Susman, Sue Morgan, FRACP, FRCPA, MBBS, Julian Cooney, MD, Mark S Currie, MD, Uday R. Popat, MD, Kenneth Bradstock, MBBS, PhD, April D. Sorrell, MD, Carolyn J. Owen, MD MDes(UK), FRCPC, Marshall S Horwitz, MD PhD, Devendra Hiwase, MBBS, FRACP, FRCPA, MD PhD, Alwin Krämer, MD, Stefan Fröhling, MD, Lucy A Godley, MD PhD, Jane E Churpek, MD, Hamish S Scott, BSc, PhD FFSc (RCPA), FAHMS

Blood (2016) 128 (22): 1212.

https://doi.org/10.1182/blood.V128.22.1212.1212

Published: 2016

Journal Articles

CD16+ Dendritic Cells Are a Unique Myeloid Antigen Presenting Cell Population

Phillip Fromm, PhD, Michael Papadimitrious, Jennifer Hsu, PhD, Stephen Robert Larsen, MBBS PhD FRCPA FRACP, John Gibson, Kenneth Bradstock, MBBS, PhD, Fiona Kupresanin, Georgina Clark, Derek NJ Hart

Blood (2016) 128 (22): 4897.

https://doi.org/10.1182/blood.V128.22.4897.4897

Published: 2016

Journal Articles

Characterisation of Human CD83 Expression on Immune Cells and Their Targeting with CD83 Antibodies to Prevent Graft Versus Host Disease in Allogeneic Haematopoietic Cell Transplantation

Blood (2015) 126 (23): 3081.

https://doi.org/10.1182/blood.V126.23.3081.3081

Published: 2015

Journal Articles

High Dose Cytarabine (HiDAC) and Fludarabine Without Anthracycline For Patients With Core Binding Factor (CBF) Acute Myeloid Leukemia (AML): The Australasian Leukaemia and Lymphoma Group (ALLG) AMLM13 Study

Paula Marlton, MBBS, John F Seymour, MBBS, PhD, Kenneth Bradstock, MBBS, PhD, Ian D Lewis, MB, BS, PhD, Russell Saal, BAppSci, MMedSci, Lyle McMillen, BSc, PhD, Juliana Di Iulio, BAppSc, PhD, Diana Zannino, BSc, MSc, Andrew Grigg, MBBS

Blood (2013) 122 (21): 1444.

https://doi.org/10.1182/blood.V122.21.1444.1444

Published: 2013

Journal Articles

Risk Factors for Blood Product Usage Following Sibling Allogeneic Haemopoietic Stem Cell Transplantation (allo-HCT).

Nicola Hurst, Charles G. Mullighan, Sue L. Heatley, Kathryn Robinson, Silke Danner, Uwe Hahn, Jeff Szer, Peter Shuttleworth, Rosie Hoyt, Anthony P. Schwarer, Jenny Muirhead, Kenneth Bradstock, Lisa Miller, Peter G. Bardy

Blood (2007) 110 (11): 2909.

https://doi.org/10.1182/blood.V110.11.2909.2909

Published: 2007

Journal Articles

Mannose-Binding Lectin Status Is Associated with Risk of Major Infection Following Myeloablative Sibling Allogeneic Hematopoietic Stem Cell Transplantation.

Charles G. Mullighan, MBBS, MSc, MD, Susan E. Heatley, B Med Sci, Silke Danner, Melinda Dean, Kathleen V. Doherty, PhD, Uwe Hahn, MD, Kenneth Bradstock, Robyn Minchinton, PhD, Anthony P. Schwarer, Jeffrey Szer, B Med Sci MBBS, Peter G. Bardy, MBBS

Blood (2006) 108 (11): 2928.

https://doi.org/10.1182/blood.V108.11.2928.2928

Published: 2006

Journal Articles

Extended TNF Genotyping Identifies TNF -857T as a Risk Factor for Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.

Charles Mullighan, MBBS, MSc, MD, Sue L. Heatley, BMedSci(Hons), Natalie R. Villalta, B Med Sci, Kathleen V. Doherty, PhD, Silke Danner, Uwe Hahn, MD, Kenneth Bradstock, MD, Anthony P. Schwarer, MD, Jeffrey Szer, B Med Sci MB BS, Peter G. Bardy, MBBS

Blood (2006) 108 (11): 39.

https://doi.org/10.1182/blood.V108.11.39.39

Published: 2006

Journal Articles

Growth requirements and immunophenotype of acute lymphoblastic leukemia progenitors

Dario Campana, Shotaro Iwamoto, Linda Bendall, Kenneth Bradstock

Blood (2005) 105 (10): 4150.

https://doi.org/10.1182/blood-2004-10-3933

Published: 2005

Journal Articles

Cladribine (CdA) or Fludarabine (F) or High-Dose Intermittent Chlorambucil (Chl) as First-Line Treatment of Symptomatic Chronic Lymphocytic Leukemia? First Interim Analysis of Data from the International Randomized Phase III Trial.

Karin Karlsson, Mats Strömberg, Viggo Jönsson, Devinder Gill, Jens Hammerström, Jonas Wallvik, Stephen Mulligan, Kenneth Bradstock, Jan Liliemark, Gunnar Juliusson

Blood (2004) 104 (11): 3470.

https://doi.org/10.1182/blood.V104.11.3470.3470

Published: 2004

Journal Articles

Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations

Susan Branford, Zbigniew Rudzki, Ian Parkinson, Andrew Grigg, Kerry Taylor, John F. Seymour, Simon Durrant, Peter Browett, Anthony P. Schwarer, Chris Arthur, John Catalano, Michael F. Leahy, Robin Filshie, Kenneth Bradstock, Richard Herrmann, David Joske, Kevin Lynch, Tim Hughes

Blood (2004) 104 (9): 2926–2932.

https://doi.org/10.1182/blood-2004-03-1134

Published: 2004

NARROW

Alterations in Circulating Lymphoid Populations after Post-Transplant Cyclophosphamide Administration in Haploidentical Hemopoietic Cell Transplantation

Expanded Phenotypic and Genetic Heterogeneity in the Clinical Spectrum of FPD-AML: Lymphoid Malignancies and Skin Disorders Are Common Features in Carriers of Germline RUNX1 Mutations

CD16+ Dendritic Cells Are a Unique Myeloid Antigen Presenting Cell Population

Characterisation of Human CD83 Expression on Immune Cells and Their Targeting with CD83 Antibodies to Prevent Graft Versus Host Disease in Allogeneic Haematopoietic Cell Transplantation

High Dose Cytarabine (HiDAC) and Fludarabine Without Anthracycline For Patients With Core Binding Factor (CBF) Acute Myeloid Leukemia (AML): The Australasian Leukaemia and Lymphoma Group (ALLG) AMLM13 Study

Risk Factors for Blood Product Usage Following Sibling Allogeneic Haemopoietic Stem Cell Transplantation (allo-HCT).

Mannose-Binding Lectin Status Is Associated with Risk of Major Infection Following Myeloablative Sibling Allogeneic Hematopoietic Stem Cell Transplantation.

Extended TNF Genotyping Identifies TNF -857T as a Risk Factor for Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.

Growth requirements and immunophenotype of acute lymphoblastic leukemia progenitors

Cladribine (CdA) or Fludarabine (F) or High-Dose Intermittent Chlorambucil (Chl) as First-Line Treatment of Symptomatic Chronic Lymphocytic Leukemia? First Interim Analysis of Data from the International Randomized Phase III Trial.

Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only